Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter July 25, 2017

Type 1 rhizomelic chondrodysplasia punctata with a homozygous PEX7 mutation

Nursel Muratoğlu Şahin, Meliha Esra Bilici, Erdal Kurnaz, Melek Pala Akdoğan, Serdar Ceylaner and Zehra Aycan



Rhizomelic chondrodysplasia punctata (RCDP) is a rare peroxisomal disease characterised by punctate calcifications of non-ossified cartilage epiphyseal centres. The main biochemical marker of all RCDP types is a decrease in the levels of plasmalogens. Additionally, the accumulation of phytanic acid can be used as a differential marker between types of RDCP. Due to the biochemical overlap between types 1 and 5 RCDP, a genetic analysis of these genes should be performed in patients to identify the type.

Case presentation:

A 2-month-19-day-old male child presented with symptoms of limited movement and discomfort with movement in the extremities. His sister, who had similar clinical findings, was diagnosed with tetralogy of Fallot and died at 6 months of age. A physical examination revealed an atypical facial appearance, bilateral cataracts, sensitivity to touch in the extremities, shortness in the proximal segments of the long bones, limited movement in both knees and elbows and axial hypotonicity. Laboratory analyses revealed normal ammonia, lactate, plasma and urine amino acids, long chain fatty acids and phytanic acid levels. Rhizomelia, significant metaphyseal expansion, irregularities in the cortex, loss of ossification, fragmented appearance and punctate calcifications in both elbows, both knees and in the femoral epiphysis were seen on the skeletal survey. A homozygote p.L70W (c.209T>G) mutation was found in the PEX7 gene.


Plasma phytanic acid levels can be normal in a patient with type 1 RCDP that develops as a result of a PEX7 gene mutation, as in our case. A molecular genetic analysis and/or fibroblast culture must be conducted in clinically suspicious cases. While no cardiac pathology was found in our case, tetralogy of Fallot was present in his sister with similar clinical findings. The presence of different cardiological phenotypes in the sibling suggested that the genotype-phenotype correlation may not be complete in this disorder.

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organisation(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.


1. Klouwer FC, Huffnagel IC, Ferdinandusse S, Waterham HR, Wanders RJ, et al. The BT. Clinical and Biochemical Pitfalls in the Diagnosis of Peroxisomal Disorders. Neuropediatrics 2016;47:205–20.10.1055/s-0036-1582140Search in Google Scholar

2. Shimozawa N. Molecular and clinical aspects of peroxisomal diseases. J Inherit Metab Dis 2007;30:193–7.10.1007/s10545-007-0516-zSearch in Google Scholar

3. Barøy T, Koster J, Strømme P, Ebberink MS, Misceo D, et al. A novel type of rhizomelic chondrodysplasia punctata, RCDP5, is caused by loss of the PEX5 long isoform. Hum Mol Genet 2015;24:5845–54.10.1093/hmg/ddv305Search in Google Scholar

4. White AL, Modaff P, Holland-Morris F, Pauli RM. Natural history of rhizomelic chondrodysplasia punctata Am J Med Genet 2003;118:332–42.10.1002/ajmg.a.20009Search in Google Scholar

5. Poll BT, Aubourg P, Wanders RJ. Peroxisomal disorders. In: Saudbray JM, Berghe GV, Walter JH, editors. Inborn metabolic diseases. Berlin, Heidelberg: Springer, 2013:591–605.Search in Google Scholar

6. Pascolat G, Zindeluk JL, Abrão KC, Rodrigues FM, Guedes CI. Rhizomelic chondrodysplasia punctata – case report. J Pediatr 2003;79:189–92.10.2223/JPED.972Search in Google Scholar

7. Steinberg SJ, Dodt G, Raymond GV, Braverman NE, Moser AB, et al. Peroxisome biogenesis disorders. Biochim Biophys Acta 2006;1763:1733–48.10.1016/j.bbamcr.2006.09.010Search in Google Scholar

8. Wanders RJ. Peroxisomal disorders. In: Rimoin DL, Pyeritz RE, Korf B, editors. Emery and Rimoin’s principles and practice of medical genetics. Amsterdam: Elsevier Ltd., 2013:1–21.Search in Google Scholar

9. Lyon G, Kolodny E, Pastores GM. eds. The neurology of neonatal hereditary metabolic diseases. In: Neurology of metabolic diseases of children. New York: McGraw Hill, 2006:9–56.Search in Google Scholar

10. Andersen PE, Justesen P. Chondrodysplasia Punctata. Report of two cases. Skeletal Radiol 1987;16:223–6.10.1007/BF00356957Search in Google Scholar

11. Bams-Mengerink AM, Koelman JH, Waterham H, Barth PG, Poll-The BT. The neurology of rhizomelic chondrodysplasia punctata. Orphanet J Rare Dis 2013;8:174.10.1186/1750-1172-8-174Search in Google Scholar

12. Barth PG, Wanders RJ, Schutgens RB, Staalman CR. Variant rhizomelic chondrodysplasia punctata (RCDP) with normal plasma phytanic acid: clinico-biochemical delineation of a subtype and complementation studies. Am J Med Genet 1996;62:164–8.10.1002/(SICI)1096-8628(19960315)62:2<164::AID-AJMG9>3.0.CO;2-WSearch in Google Scholar

13. Jacobsen JC, Glamuzina E, Taylor J, Swan B, Handisides S, et al. Whole exome sequencing reveals compound heterozygosity for ethnically distinct PEX7 mutations responsible for rhizomelic chondrodysplasia punctata, type 1. Case Rep Genet 2015;2015:454526.10.1155/2015/454526Search in Google Scholar

14. Huffnagel IC, Clur SA, Bams-Mengerink AM, Blom NA, Wanders RJ, et al. Rhizomelic chondrodysplasia punctata and cardiac pathology. J Med Genet 2013;50:419–24.10.1136/jmedgenet-2013-101536Search in Google Scholar PubMed

Received: 2016-8-9
Accepted: 2017-6-15
Published Online: 2017-7-25
Published in Print: 2017-8-28

©2017 Walter de Gruyter GmbH, Berlin/Boston

Scroll Up Arrow